EV/EBITDA:
-19.32-0.31(-1.63%)Summary
- As of today (May 30, 2025), AXSM EV/EBITDA is -19.32, with a fall of -0.31 (-1.63%) during the most recent trading session on May 29, 2025.
- Over the past year, AXSM EV/EBITDA has dropped by -7.18 (-59.14%).
- AXSM EV/EBITDA is now -1386.15% below its all-time high of -1.30.
Performance
AXSM EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AXSM EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.6% | +1.6% | +1.6% |
| 1 m1 month | +4.9% | -4.9% | -4.8% |
| 3 m3 months | +15.2% | -18.5% | -18.0% |
| 6 m6 months | -21.2% | +6.4% | +6.5% |
| ytdytd | - | - | +23.7% |
| 1 y1 year | -59.1% | +46.0% | +39.1% |
| 5 y5 years | +35.7% | +89.1% | +35.9% |
AXSM EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -19.01 | -1.6% | -21.55 | +10.3% |
| 3 m | 3-month | -17.63 | -9.6% | -22.79 | +15.2% |
| 6 m | 6-month | -13.34 | -44.8% | -24.36 | +20.7% |
| 1 y | 1-year | -11.32 | -70.7% | -24.36 | +20.7% |
| 3 y | 3-year | -6.06 | -218.8% | -27.29 | +29.2% |
| 5 y | 5-year | -6.06 | -218.8% | -33.69 | +42.6% |
| alltime | all time | -1.30 | -1386.2% | -74.77 | +74.2% |
AXSM EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -19.32(+21.7%) |
| 2023 | -15.88(-14.3%) |
| 2022 | -18.52(+64.3%) |
| 2021 | -11.27(-61.2%) |
| 2020 | -29.04(-46.2%) |
| Date | Value |
|---|---|
| 2019 | -53.94(+1966.7%) |
| 2018 | -2.61(-39.4%) |
| 2017 | -4.31(+13.7%) |
| 2016 | -3.79(-66.2%) |
| 2015 | -11.21 |
FAQ
- What is Axsome Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Axsome Therapeutics?
- What is Axsome Therapeutics EV/EBITDA year-on-year change?
What is Axsome Therapeutics EV/EBITDA?
The current EV/EBITDA of AXSM is -19.32
What is the all time high EV/EBITDA for Axsome Therapeutics?
Axsome Therapeutics all-time high EV/EBITDA is -1.30
What is Axsome Therapeutics EV/EBITDA year-on-year change?
Over the past year, AXSM EV/EBITDA has changed by -7.18 (-59.14%)